Ruiqi Wang

State Key Laboratory Of Oncology In South China, PR
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Efficacy of immune checkpoint inhibitors combined with different chemotherapy in recurrent pancreatic cancer: a retrospective study.

Efficacy of immune checkpoint inhibitors combined with different chemotherapy in recurrent pancreatic cancer: a retrospective study.

Journal: Frontiers in immunology

Published: March 30, 2026

A STING signaling relay from tumor cells to macrophages mediates the improved efficacy of combination chemotherapy in pancreatic cancer.

A STING signaling relay from tumor cells to macrophages mediates the improved efficacy of combination chemotherapy in pancreatic cancer.

Journal: Journal of biomedical science

Published: August 19, 2025

Identification of SETD4 as an Onco-Immunological Biomarker Encompassing the Tumor Microenvironment, Prognoses, and Therapeutic Responses in Various Human Cancers.

Identification of SETD4 as an Onco-Immunological Biomarker Encompassing the Tumor Microenvironment, Prognoses, and Therapeutic Responses in Various Human Cancers.

Journal: Immunity, inflammation and disease

Published: June 11, 2024

The tRNA Gm18 methyltransferase TARBP1 promotes hepatocellular carcinoma progression via metabolic reprogramming of glutamine.

The tRNA Gm18 methyltransferase TARBP1 promotes hepatocellular carcinoma progression via metabolic reprogramming of glutamine.

Journal: Cell death and differentiation

Published: October 20, 2023

Prognostic effect of CD73 in pancreatic ductal adenocarcinoma for disease-free survival after radical surgery.

Prognostic effect of CD73 in pancreatic ductal adenocarcinoma for disease-free survival after radical surgery.

Journal: Journal of cancer research and clinical oncology

Published: January 27, 2023

Serum Amyloid a Predicts Prognosis and Chemotherapy Efficacy in Patients with Advanced Pancreatic Cancer.

Serum Amyloid a Predicts Prognosis and Chemotherapy Efficacy in Patients with Advanced Pancreatic Cancer.

Journal: Journal of inflammation research

Published: January 15, 2023

TRIB3 promoter 33 bp VNTR is associated with the risk of cerebrovascular disease in type 2 diabetic patients.

TRIB3 promoter 33 bp VNTR is associated with the risk of cerebrovascular disease in type 2 diabetic patients.

Journal: Frontiers in genetics

Published: April 29, 2022

An Inflammatory Response-Related Gene Signature Reveals Distinct Survival Outcome and Tumor Microenvironment Characterization in Pancreatic Cancer.

An Inflammatory Response-Related Gene Signature Reveals Distinct Survival Outcome and Tumor Microenvironment Characterization in Pancreatic Cancer.

Journal: Frontiers in molecular biosciences

Published: February 15, 2022

Predictive value of a novel lncRNA LINC02518 in evaluating the prognosis of patients with hepatocellular carcinoma.

Predictive value of a novel lncRNA LINC02518 in evaluating the prognosis of patients with hepatocellular carcinoma.

Journal: Biomarkers in medicine

Published: September 06, 2021

SYPL1 Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma via Suppression of ROS-Induced ERK Activation.

SYPL1 Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma via Suppression of ROS-Induced ERK Activation.

Journal: Frontiers in oncology

Published: April 30, 2020

Multiple primary malignancies for squamous cell carcinoma and adenocarcinoma of the esophagus.

Multiple primary malignancies for squamous cell carcinoma and adenocarcinoma of the esophagus.

Journal: Journal of thoracic disease

Published: September 28, 2019

MicroRNA-18a promotes cancer progression through SMG1 suppression and mTOR pathway activation in nasopharyngeal carcinoma.

MicroRNA-18a promotes cancer progression through SMG1 suppression and mTOR pathway activation in nasopharyngeal carcinoma.

Journal: Cell death & disease

Published: June 12, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026